Lung Cancer: CTSU 5508 Stage IIB or IV (1st or 2nd Line)
"CTSU E5508 Randomized Phase III Study of Maintenance Therapy with Bevacizumab, Pemetrexed, or a Combination of Bevacizumab and Pemetrexed Following Carboplatin, Paclitaxel and Bevacizumab for Advanced Non-Squamous NSCLC
"No prior systemic chemotherapy for advanced stage lung cancer. Prior adjuvant chemotherapy is allowed if at least 12 months have elapsed since the
prior chemotherapy administration and registration. Prior RT ok, no squamous "